Viemed Healthcare, Inc.
Symbol: VMD
NASDAQ
9.38
USDTrhová cena dnes
26.7260
Pomer P/E
0.0462
Pomer PEG
361.03M
MRK Cap
- 0.00%
Výnos DIV
Viemed Healthcare, Inc. (VMD) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 12.8 | 16.9 | 28.4 | ||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -2 | 0 | ||||||||
balance-sheet.row.net-receivables | 0 | 18.4 | 15.4 | 14.7 | ||||||||
balance-sheet.row.inventory | 0 | 4.6 | 3.6 | 2.5 | ||||||||
balance-sheet.row.other-current-assets | 0 | 2.4 | 3.8 | 1.7 | ||||||||
balance-sheet.row.total-current-assets | 0 | 38.2 | 39.7 | 47.3 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 76.5 | 68.4 | 62.8 | ||||||||
balance-sheet.row.goodwill | 0 | 29.6 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0.6 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 30.3 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 0 | 3.9 | 4.2 | 2.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 4.5 | 3.1 | 4.8 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.7 | 1.6 | 0.9 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 115.9 | 77.3 | 70.7 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.account-payables | 0 | 4.2 | 2.6 | 3.2 | ||||||||
balance-sheet.row.short-term-debt | 0 | 2 | 0.5 | 1.9 | ||||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6 | 0.2 | 4.6 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 19.6 | 11.1 | 8.9 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8.8 | 1.1 | 5.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.3 | 0.7 | 0.7 | ||||||||
balance-sheet.row.total-liab | 0 | 40.8 | 19.9 | 23.1 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.3 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 18.6 | 15.1 | 14 | ||||||||
balance-sheet.row.retained-earnings | 0 | 79.1 | 69.8 | 73.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.3 | -0.3 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 15.6 | 12.1 | 7.7 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 3.9 | 2.2 | 2.2 | ||||||||
balance-sheet.row.total-debt | 0 | 10.3 | 0.7 | 6.5 | ||||||||
balance-sheet.row.net-debt | 0 | -2.5 | -16.2 | -21.9 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 10.4 | 6.2 | 9.1 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 22.3 | 15.6 | 11.3 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -1.5 | 1.7 | 3.9 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 5.8 | 5.2 | 5.2 | ||||||||
cash-flows.row.change-in-working-capital | 0 | 7.9 | -10.1 | -13.6 | ||||||||
cash-flows.row.account-receivables | 0 | -1.1 | -12.6 | -7.3 | ||||||||
cash-flows.row.inventory | 0 | -0.5 | 0.3 | -0.2 | ||||||||
cash-flows.row.account-payables | 0 | -0.9 | -0.3 | 0.1 | ||||||||
cash-flows.row.other-working-capital | 0 | 10.4 | 2.4 | -6.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 1 | 9.1 | 6.6 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.acquisitions-net | 0 | -26.5 | -0.1 | -0.6 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -0.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -2.6 | 0 | 0.6 | ||||||||
cash-flows.row.other-investing-activites | 0 | 2.6 | 1.1 | 0.6 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -53.1 | -24 | -19.7 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.3 | -5.8 | -4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 1.3 | 0.3 | 0.1 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.6 | -9.7 | -1.4 | ||||||||
cash-flows.row.dividends-paid | 0 | -0.4 | -0.3 | -0.1 | ||||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.3 | 0.1 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2.9 | -15.3 | -5.3 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 6.9 | -11.5 | -2.6 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 12.8 | 16.9 | 28.4 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 5.9 | 28.4 | 31 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 46 | 27.7 | 22.5 | ||||||||
cash-flows.row.capital-expenditure | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.free-cash-flow | 0 | 19.5 | 4.8 | 2.8 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 186.4 | 138.8 | 117.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 72.9 | 54.2 | 43.7 | ||||||||
income-statement-row.row.gross-profit | 0 | 113.4 | 84.7 | 73.4 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.operating-expenses | 0 | 97.6 | 76.1 | 61.4 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 170.6 | 130.2 | 105 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 0.3 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 22.3 | 16.3 | 12.2 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 15.8 | 8.3 | 11.6 | ||||||||
income-statement-row.row.income-before-tax | 0 | 14.7 | 9 | 12.5 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 4.2 | 2.8 | 3.4 | ||||||||
income-statement-row.row.net-income | 0 | 10.2 | 6.2 | 9.1 |
Často kladené otázky
Čo je Viemed Healthcare, Inc. (VMD) celkové aktíva?
Viemed Healthcare, Inc. (VMD) celkové aktíva sú 154102510.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.609.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 0.228.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.053.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.077.
Aká je Viemed Healthcare, Inc. (VMD) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 10243000.000.
Aký je celkový dlh firmy?
Celkový dlh je 10271179.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 97637306.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.